Avrio Biopharmaceuticals

11 articles about Avrio Biopharmaceuticals

• 

  Biopharma Update on the Novel Coronavirus: May 20

  5/20/2020

  Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 20, 2020.

• Nitto Denko Avecia Inc. Acquires The Businesses Of Irvine Pharmaceutical Services, Inc. & Avrio Biopharmaceuticals

  10/12/2016

• Hemispherx Reaches Agreement With Avrio Biopharmaceuticals For The Accelerated Production Of Ampligen

  7/27/2016

• Avrio Biopharmaceuticals Appoints William P. Botha as President

  3/22/2012

• Avrio Biopharmaceuticals Purchases a New Lyophilizer and Liquid Vial Filling Machine - New Capabilities and Added Capacity

  9/14/2011

• Avrio Biopharmaceuticals Receives ISO 13485:2003 Certification for Medical Device Manufacturing

  10/29/2010

• Avrio Biopharmaceuticals Appoints David L. Gelber to Director of Manufacturing

  6/29/2010

• Avrio Biopharmaceuticals Selects EXTEDO eCTDmanager Suite to Manage Regulatory Submissions Worldwide

  3/30/2010

• Yvonne Verburgt Joins the Avrio Biopharmaceuticals Executive Team as Vice President of Business Development and Marketing

  3/3/2010

• Avrio Biopharmaceuticals Receives Drug Manufacturing License and Medical Device Manufacturing License from the California Food and Drug Branch

  2/10/2010

• Irvine Pharmaceutical Services, Inc. Introduces New Fill-And-Finish Subsidiary; January 2009 Launch of Avrio Biopharmaceuticals

  11/11/2008